Effects of inflammation on irinotecan pharmacokinetics and development of a best-fit PK modelPavan Kumar Chityala, Romi Ghose, Lei Wu et al.|Chemico-Biological Interactions|2019Cited by 10
A Pharmacokinetic Study of Irinotecan (CPT‐11) During Inflammation in MicePavan Kumar Chityala, Romi Ghose, Guncha Taneja et al.|The FASEB Journal|2018Cited by 1
Role of Inflammation in Irinotecan (CPT‐11) Pharmacokinetics: A PK Study and Development of a Best‐fit Pharmacokinetic Model of Irinotecan and Its Active Metabolite, SN‐38 in Mice with and without InflammationPavan Kumar Chityala, Romi Ghose, Lei Wu et al.|The FASEB Journal|2019Cited by 0